Effect of simultaneous vaccination with H1N1 and GAD-alum on GAD65-induced immune response
Sign Up to like & getrecommendations! Published in 2017 at "Diabetologia"
DOI: 10.1007/s00125-017-4263-x
Abstract: Aims/hypothesisA European Phase III trial of GAD formulated with aluminium hydroxide (GAD-alum) failed to reach its primary endpoint (preservation of stimulated C-peptide secretion from baseline to 15 months in type 1 diabetes patients), but subgroup analysis… read more here.
Keywords: gad alum; alum; vaccination; gad65 induced ... See more keywords